Key result
Pimobendan demonstrated significant improvements in exercise capacity and quality of life in patients with heart failure across five controlled, randomized prospective trials.
Why the study?
Does pimobendan improve exercise capacity and quality of life in patients with advanced heart failure?
Population
Patients with advanced heart failure (based on data from 5 controlled, randomized prospective trials)
Design
Review
Authors
Loading...
May support symptom relief in HF; leaves open mortality effects and long-term outcomes.
Does pimobendan improve exercise capacity and quality of life in patients with advanced heart failure?
Pimobendan may serve as a useful adjunctive therapy to improve exercise tolerance and quality of life in advanced heart failure, though its impact on mortality requires further investigation.
Spencer H. Kubo (2008) conducted a review in Heart failure. Pimobendan was evaluated on Exercise capacity and quality of life. Pimobendan demonstrated significant improvements in exercise capacity and quality of life in patients with heart failure across five controlled, randomized prospective trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: